Sempra (SRE) insider files Form 144 for 5,500-share sale

Rhea-AI Filing Summary

Sempra (SRE) has a planned sale of restricted stock that recently vested. A person related to the company filed a Form 144 to potentially sell 5,500 shares of Sempra common stock through broker Oppenheimer & Co., Inc. on the NYSE, with an indicated aggregate market value of 507,100.00. The table notes that 652,681,521 shares of common stock were outstanding.

The securities were acquired on 01/28/2025 through the vesting of restricted stock units granted under Sempra's Long-Term Incentive Plan, described as an equity award received as compensation. The signer represents that they are not aware of any undisclosed material adverse information about Sempra’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Oppenheimer & Co., Inc. 10880 Wilshire Boulevard Los Angeles CA 90024	5500	507100.00	652681521	11/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/28/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			5500	01/28/2025	Vesting of equity award received as compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Sempra (SRE)'s latest Form 144 filing disclose?

The Form 144 indicates an affiliate of Sempra (SRE) may sell 5,500 shares of common stock through Oppenheimer & Co., Inc. on the NYSE, with an aggregate market value of 507,100.00.

How many Sempra (SRE) shares are involved in this Form 144 sale?

The notice covers a potential sale of 5,500 shares of Sempra common stock, with an indicated aggregate market value of 507,100.00.

How and when were the Sempra (SRE) shares being sold acquired?

The 5,500 shares were acquired on 01/28/2025 through vesting of a grant of restricted stock units under Sempra's Long-Term Incentive Plan, described as an equity award received as compensation.

Which broker and exchange are listed for the Sempra (SRE) Form 144 transaction?

The planned sale lists Oppenheimer & Co., Inc. as broker, with trades to occur on the NYSE.

How many Sempra (SRE) shares are outstanding according to this notice?

The table reports 652,681,521 shares of Sempra common stock outstanding.

What assurance does the seller provide in the Sempra (SRE) Form 144?

The person for whose account the securities may be sold represents that they do not know any material adverse information about Sempra’s current or prospective operations that has not been publicly disclosed.